Menopause Completed Phase 4 Trials for Lisdexamfetamine (DB01255)

Also known as: Menopausal

IndicationStatusPhase
DBCOND0025857 (Menopause)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01977625LDX and Functional Magnetic Resonance Imaging (fMRI in Menopausal WomenTreatment